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another with IMRT. The original plans delivered to the 
patients were not considered in this study because treatment 
techniques have been changing since 2000 and were not 
uniform within the selected group. All plans assured PTV 
coverage according to ICRU 83 criteria. Cochleas and 
supratentorial brain mean doses, as organs , were analyzed 
using QUANTEC values and compared for each plan. 
 
Results: Among 29 children, 22 were males. The median age 
at diagnosis was 8.66 years. At the beginning of treatment, 
their age range from 3.26 to 15.47 years old. The average 
mean dosesto the OAR analyzed are presented in Table 1. 
Table 1: Average Mean Doses to OARs 
 
 
 
Conclusion: The plans for the CRT technique, with 2 parallel 
opposed fields, produced worst results for both OARs. The 
IMRT technique was slightly superior to the 3D-CRT in terms 
of mean dose of cochleas but conducted, in average, to 
higher dose values to the supratentorial brain. Based on 
these results we decided to adopt the 3D-CRT technique for 
the boost phase in high-risk group and IMRT for the standard-
risk group, considering the higher potencial impact in the 
cochleas mean doses in this risk-group.  
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Purpose or Objective: This work is to present the treatment 
planning workflow and delivery technique for the first 
application of linac based spatially fractionated mini-beam 
radiotherapy within a clinical trial of canine brain tumor 
treatments. The motivation for this investigation originates 
from work performed using synchrotron generated micro-
beams (MRT) which have shown promising results in 
preserving brain architecture while killing tumor cells. 
Spatial fractionation of radiation using arrays of parallel 
micro-planar beams is a developing technique with many 
unknowns and limitations. To further research this technique 
and to potentially enable MRT for human treatments, a mini-
beam collimator has been designed for use with a linac and a 
Monte Carlo (MC) beam model has been commissioned for 
clinical treatment planning. 
 
Material and Methods: Patient population was selected from 
client-owned canines with spontaneously occurring brain 
tumors. Patients were placed under general anesthesia and 
positioned prone within stereotactic immobilization 
equipment during imaging and treatment delivery. CT and 
MRI images were used for contouring. The planning technique 
utilized an arrangements of static mini-beams. Beam angles 
were chosen such that the treatment depth was within 20% 
for each beam to minimize beam broadening with depth and 
blurring of the peak and valley doses. Beam apertures were 
defined with the MLC leaves set 3 mm back from the PTV. 
The mini-beam collimated dose distributions were calculated 
to a statistical uncertainty of ±1.0 % within a voxel size of 0.5 
mm. Beam weighting was equalized and the plan normalized 
such that the prescription dose was delivered to an ICRU dose 
reference point within the PTV. Deliver quality assurance 
(DQA) was performed by measuring the absolute dose from 
each beam using an ion chamber within a solid water 
phantom. 
 
Results: Contouring and beam arrangement, which included 
MLC placement, was performed within the clinical treatment 
planning system (TPS). The DICOM plan was then exported to 
the MC treatment planning system for mini-beam dose 
calculation. The distribution was reviewed and DVHs assessed 
for normal tissue tolerances. The final step was to transcribe 
the calculated MUs back to the original TPS. Planning 
turnaround time was 2 days. The MC calculations were 
initiated overnight at the end of day 1. Day 2 was spent 
reviewing the plan, generating the DQA plan, and finalizing 
the treatment parameters into the record-and-verify system 
(RVS). DQA output measurements of the treatment fields 
agreed with the calculated dose to within 1.5%. An image of 
the patient dose distribution and setup is shown in figure 1. 
 
 
Conclusion: A workflow for mini-beam treatments that 
includes the planning technique, MC dose calculation 
method, DQA process, and data integration into a RVS has 
been established. This clinical dataset represents the first 
treatment planning study of linac based mini-beam patients. 
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Purpose or Objective: The aim of this study is to investigates 
different strategies in choosing, in a mathematical way, the 
structure set that best fit a Dose Painting (DP) distribution, 
based on ADC maps, to be submitted to the optimization 
process within the TomoTherapy TPS. 
 
Material and Methods: Hypofractionated Stereotactic 
Radiation Therapy plans in 5 fractions of intracranial GBM for 
six patients were retrospectively realized. 
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A non-uniform Dose Painting By Numbers Dose Distribution 
(DPBN) was obtained from an ADC map of each patient 
registered with the planning CT scan. The pixels values 
within the CTV of the registered ADC maps were converted to 
dose values through the function of Eq. 1, where Dmin = 25 
Gy, Dmax = 50 Gy, Imin = 500 mm2/s e Imax = 1500 mm2/s. 
According to Deveau et al., (Acta Oncol. 2010) 9 isodose 
levels of the DPBN should be converted into structures in 
order to restrict the number of planning structures in the TPS 
optimization step. Four different methods to select the 
isodose levels were implemented. 
IsoDose Method (IDM). The dose interval prescription is 
divided in 9 equal sub-intervals (Fig. 1.a). In this way the 
sub-intervals are dependent on the dose prescription interval 
only. 
IsoVol Method (IVD). The volume of the CTV structure is 
divided in 9 equal subvolumes (Fig. 1.b). The absolute DVH of 
the DPBN of the CTV allows to associate to each volume value 
(cm^3) a dose value. These are used as the isolevels to be 
converted in structures. 
IsoVD Method (IVDM). An arbitrary function, indicated as 
∆DV, was defined in Eq. 2 where Dmin and Dmax are the 
minimum and maximum prescribed dose, Vmax is the total 
volume of the CTV, Di and Vi are the dose and the volume at 
the point i in the DVH line. Dividing the ∆DV(Di) function in 9 
equi-spaced interval, as in Fig. 1.c, the corresponding dose 
values, from which derive the sub-structure for the 
optimization, were found. 
minQF Method (mQM). Starting from a structure set of 9 
isolevels obtained from DPBN, it is possible to calculate a 
Dose Painting By Contours Dose Distribution (DPBC), assigning 
to each voxel pertaining to the isolevels k a uniform dose of 
value Dk. This method imposes that the Quality Factor (QF), 
in Eq. 3-4 (Vanderstraeten et al., Phys. Med. Biol. 2006), 
between the DPBN and the DPBC be as close as possible to 
zero, using a genetic minimization algorithm (Matlab). 
In order to estimate which method returns the DPBC more 
consistent with the DPBN, the QF and the QVH were 
computed for each method. 
 
 
 
Results 
Comparing the four methods, the results in Table 1 show that 
the mQM provides QF values closest to zero for six patients 
and that only in one patient the IVD is better than the mQM 
only of about 1 %. Also QVHs show lines more about to 1 for 
the mQM. 
 
 
Conclusion: A robust and mathematical method in order to 
select the structure set that better fit a Dose Painting 
distribution was found in the mQM method. This method 
could be employed regardless the way used to obtained the 
Dose Painting distribution. 
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Purpose or Objective: Brain metastases occur in 20–40 % of 
patients affected by primary solid tumors. Radiosurgery (SRS) 
was demonstrated to be safe and efficient for the brain 
metastases control. SRS can be delivered with dedicated 
equipment, like GammaKnife, or with conventional LINAC. 
Few comparative studies have been conducted. In our 
institution we designed a phase III randomized trial to 
evaluate cerebral side effects following SRS delivered by 
Gamma Knife Perfexion and Linac EDGE 
 
Material and Methods: Patients with 1 to 4 brain metastases, 
from any primary except for small cell lung cancer (SCLC) or 
Lymphoproliferative disease, suitable for SRS were 
randomized to receive the treatment with GammaKnife or 
Linac. Primary end point was the symptomatic radionecrosis 
incidence; brain LC, DFS and OS were secondary end points. 
Planning parameters, including target coverage for accepted 
surface dose levels, paddick conformity index (PCI), gradient 
index (GI), homogeneity index (HI), maximum and minimum 
dose to the target were determined. Beam on time (BOT) was 
also recorded 
 
Results: Until now, 26 patients with 39 metastases (range 1-
3) were enrolled in this phase III trial (12 GK, 14 Linac-EDGE). 
Median prescribed dose was 24 GY (range 21-24 Gy). Most 
common primary cancers were breast and melanoma. At the 
time of analysis 3 patients died. Follow up evaluation was 
available in 12 cases. No local progression was observed, 4 
patients had a further intracranial progression. Until now, no 
radionecrosis was recorded. PCI was better for linac-based 
plans (0.93 vs 0.82), in contrast, a better GI for gamma knife 
was observed (2.5 vs 3.5). Due to the specific characteristics 
of the two delivery systems, HI was lower for linac (0.14 vs 
0.80). BOT was lower for linacs (within 2 min for each target 
vs 35 min). In our center, linac based immobilization was 
made by an open mask setup (qfix); CBCT-based IGRT was 
applied; patients were monitored by optical surface 
monitoring system (OSMS) during the delivery. Gamma knife 
immobilization was performed by the traditional stereotactic 
head frame by Elekta. For this reason, no specific online 
imaging or tracking device was required 
 
Conclusion: These are very preliminary results of a 
randomized phase III trial recently started in our institution. 
No significant clinical data can be provided yet, because of 
the short follow up time and the small number of enrolled 
patients. On the dosimetry side, the two systems have 
different characteristics and markedly different ways to 
prescribe dose. For linacs, a better dose distribution was 
obtained on the target rather than for normal tissues, even 
though no specific side effects were reported. In addition, 
